Abstract: A safety gate has: a structural frame including a pair of columns spaced from one another along a peripheral edge of an elevated platform to define a ledge entrance to a staging area of the elevated platform; a ledge gate; and a staging gate; and in which the ledge gate and the staging gate are connected to move together relative to the pair of columns: into a loading configuration when the ledge gate rises and pitches upward, and the staging gate lowers and unfolds laterally away from the pair of structural columns, to allow a) the ledge gate to open the ledge entrance and b) the staging gate to enclose the staging area; and into an unloading configuration when the ledge gate lowers and pitches downward, and the staging gate rises and folds laterally toward the pair of structural columns, to allow a) the ledge gate to close the ledge entrance and b) the staging gate to expose the staging area.

Abstract: The present invention relates to pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof. In particular, the present invention relates to a method of inducing satiation in a subject in need thereof comprising administering to the subject an effective amount of a ClpB protein or an effective amount of a bacterium that expresses the ClpB protein.

Abstract: The present invention relates to method of preventing, treating or attenuating obesity-related manifestations in a human or non-human mammal subject in need thereof, said method comprising orally administering to the subject a composition comprising an effective amount Hafnia alvei probiotics; wherein said obesity-related parameters are selected from the group of hyperphagia, increased fat mass on lean mass ratio, increased waist circumference, postprandial hyperglycemia, fasting hyperglycemia and hypercholesterolemia.

Abstract: The present invention relates to method of preventing, treating or attenuating obesity-related manifestations in a human or non-human mammal subject in need thereof, said method comprising orally administering to the subject a composition comprising an effective amount Hafnia alvei probiotics; wherein said obesity-related parameters are selected from the group of hyperphagia, increased fat mass on lean mass ratio, increased waist circumference, postprandial hyperglycemia, fasting hyperglycemia and hypercholesterolemia.

Abstract: The present invention relates to pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof. In particular, the present invention relates to a method of inducing satiation in a subject in need thereof comprising administering to the subject an effective amount of Hafnia alvei.

Abstract: The present invention relates to pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof. In particular, the present invention relates to a method of inducing satiation in a subject in need thereof comprising administering to the subject an effective amount of a ClpB protein or an effective amount of a bacterium that expresses the ClpB protein.

Abstract: The present invention relates to ClpB expressing bacteria and their impact on obesity. The present invention relates to bacterial ClpB protein and ClpB expressing bacteria and their impact on eating disorders. The invention further relates to compositions comprising antibiotic directed against at least one ClpB expressing bacterium as well as probiotics not expressing ClpB protein and their use in the treatment or prevention of eating disorders. The invention also relates to diagnostic tools for determining whether a subject is likely to respond to a method of treating eating disorders and to methods of immunization against eating disorders.

Abstract: The present invention relates to pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof. In particular, the present invention relates to a method of inducing satiation in a subject in need thereof comprising administering to the subject an effective amount of a ClpB protein or an effective amount of a bacterium that expresses the ClpB protein.

Abstract: The present invention relates to pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof. In particular, the present invention relates to a method of inducing satiation in a subject in need thereof comprising administering to the subject an effective amount of Hafnia alvei.

Abstract: The present invention relates to CIpB expressing bacteria and their impact on obesity. The present invention relates to bacterial CIpB protein and CIpB expressing bacteria and their impact on eating disorders. The invention further relates to compositions comprising antibiotic directed against at least one CIpB expressing bacterium as well as probiotics not expressing CIpB protein and their use in the treatment or prevention of eating disorders. The invention also relates to diagnostic tools for determining whether a subject is likely to respond to a method of treating eating disorders and to methods of immunization against eating disorders.

Abstract: The present invention relates to pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof. In particular, the present invention relates to a method of inducing satiation in a subject in need thereof comprising administering to the subject an effective amount of a ClpB protein or an effective amount of a bacterium that expresses the ClpB protein.

Abstract: The present invention relates to pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof. In particular, the present invention relates to a method of inducing satiation in a subject in need thereof comprising administering to the subject an effective amount of a ClpB protein or an effective amount of a bacterium that expresses the ClpB protein.

Abstract: Method and computer system for rendering damaged-enhanced images in an interactive computer simulation comprising an interactive computer generated environment. During the simulation, an input is received from a user of the simulation for triggering a virtual impact having an effective radius and coordinates of the virtual impact are determined on at least one 3D polygon mesh of the interactive computer generated environment. Thereafter, simplified calculation of at least one newly formed 3D polygon mesh from the virtual impact at the coordinates is performed by removing a portion of a sphere, computed from the effective radius, from the at least one 3D polygon mesh, thereby defining the newly formed 3D polygon mesh(es). At least one damaged-enhanced image is then rendered for display of the newly formed 3D polygon mesh(es) from a field of view of the user of the interactive computer simulation.

Abstract: The present invention relates to bacterial Clp B protein and Clp B expressing bacteria and their impact on eating disorders. The invention further relates to compositions comprising antibiotic directed against at least one Clp B expressing bacterium as well as probiotics not expressing Clp B protein and their use in the treatment or prevention of eating disorders. The invention also relates to diagnostic tools for determining whether a subject is likely to respond to a method of treating eating disorders and to methods of immunization against eating disorders.

Abstract: Method and computer system for rendering damaged-enhanced images in a computer simulation comprising a computer generated environment. During the computer simulation, determining coordinates of a virtual impact having an effective radius on 3D polygon mesh(es) of the computer generated environment, identifying rendering faces of the 3D polygon mesh(es) affected by the virtual impact, clipping at runtime the affected rendering faces to a mathematically-defined subtraction shape computed considering the effective radius, computing newly formed 3D polygon mesh(es) and rendering at least one damaged-enhanced image for display comprising a subset of rendering faces of the newly formed 3D polygon mesh(es) using a visual texture, the subset being determined from a field of view of the computer simulation.

Abstract: Method and computer system for rendering damaged-enhanced images in a computer simulation comprising a computer generated environment. During the computer simulation, determining coordinates of a virtual impact having an effective radius on 3D polygon mesh(es) of the computer generated environment, identifying rendering faces of the 3D polygon mesh(es) affected by the virtual impact, clipping at runtime the affected rendering faces to a mathematically-defined subtraction shape computed considering the effective radius, computing newly formed 3D polygon mesh(es) and rendering at least one damaged-enhanced image for display comprising a subset of rendering faces of the newly formed 3D polygon mesh(es) using a visual texture, the subset being determined from a field of view of the computer simulation.